Exelixis Historical Cash Flow
| EXEL Stock | USD 36.92 0.21 0.57% |
Analysis of Exelixis cash flow over time is an excellent tool to project Exelixis future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 24.4 M or Depreciation of 30.2 M as it is a great indicator of Exelixis ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Exelixis latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Exelixis is a good buy for the upcoming year.
Exelixis |
About Exelixis Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Exelixis balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Exelixis's non-liquid assets can be easily converted into cash.
Exelixis Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Exelixis to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Exelixis operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Exelixis' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Exelixis current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.At this time, Exelixis' Net Income is quite stable compared to the past year. Change To Inventory is expected to rise to about 5.7 M this year, although the value of Change In Working Capital is projected to rise to (12.8 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 138.5M | 163.0M | 66.2M | 69.5M | Depreciation | 20.9M | 25.7M | 28.8M | 30.2M |
Exelixis cash flow statement Correlations
Click cells to compare fundamentals
Exelixis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Exelixis cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 52.6M | 343.1M | (161.2M) | (239.7M) | (45.6M) | (43.3M) | |
| Free Cash Flow | 178.6M | 336.6M | 224.2M | 170.4M | 700.0M | 735.0M | |
| Change In Working Capital | (40.1M) | (39.0M) | (12.8M) | (14.0M) | (13.5M) | (12.8M) | |
| Begin Period Cash Flow | 268.1M | 320.8M | 663.9M | 502.7M | 263.0M | 184.4M | |
| Other Cashflows From Financing Activities | (25.1M) | (14.8M) | 586K | 4.3M | 23.2M | 24.4M | |
| Depreciation | 9.1M | 13.6M | 20.9M | 25.7M | 28.8M | 30.2M | |
| Capital Expenditures | 30.3M | 64.2M | 138.5M | 163.0M | 66.2M | 69.5M | |
| Total Cash From Operating Activities | 209.0M | 400.8M | 362.6M | 333.3M | 700.0M | 735.0M | |
| Net Income | 111.8M | 231.1M | 182.3M | 207.8M | 521.3M | 547.3M | |
| Total Cash From Financing Activities | (25.1M) | (14.8M) | 586K | (546.1M) | (628.8M) | (597.4M) | |
| End Period Cash Flow | 320.8M | 663.9M | 502.7M | 263.0M | 217.4M | 193.7M | |
| Change To Inventory | (21.9M) | (13.2M) | (11.7M) | (13.0M) | 5.5M | 5.7M | |
| Other Non Cash Items | 7.9M | 28.8M | 125.0M | 140.7M | 115.5M | 121.3M | |
| Other Cashflows From Investing Activities | (100.9M) | (67.0M) | (138.5M) | (122.5M) | (66.2M) | (69.5M) | |
| Change To Liabilities | 44.1M | 51.1M | 66.1M | (37.2M) | (42.8M) | (40.7M) | |
| Total Cashflows From Investing Activities | (587.2M) | (131.2M) | (42.9M) | (524.4M) | (472.0M) | (448.4M) | |
| Change To Account Receivables | (42.5M) | (122.3M) | 66.8M | (22.6M) | (28.0M) | (26.6M) | |
| Stock Based Compensation | 105.1M | 119.8M | 107.6M | 106.3M | 93.8M | 98.5M | |
| Sale Purchase Of Stock | (50.0M) | (39.1M) | 23.9M | (550.4M) | (652.0M) | (619.4M) | |
| Investments | (100.9M) | 21.3M | (386.0M) | (334.5M) | (116.8M) | (122.6M) | |
| Change Receivables | (89.9M) | 43.7M | (42.5M) | 66.8M | 76.9M | 80.7M | |
| Cash And Cash Equivalents Changes | 127.6M | (47.7M) | 52.6M | (161.2M) | (145.1M) | (137.8M) | |
| Cash Flows Other Operating | 5.7M | (12.2M) | (22.1M) | (12.4M) | (11.2M) | (10.6M) | |
| Change To Netincome | 127.7M | 123.4M | 195.1M | 153.9M | 177.0M | 185.9M | |
| Change To Operating Activities | (5.7M) | (25.8M) | 30.4M | (91.3M) | (82.2M) | (78.1M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.754 | Earnings Share 1.76 | Revenue Per Share | Quarterly Revenue Growth 0.182 | Return On Assets |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.